Annual Operating Expenses
$129.45 M
+$42.34 M+48.61%
31 December 2023
Summary:
Spyre Therapeutics annual total operating expenses is currently $129.45 million, with the most recent change of +$42.34 million (+48.61%) on 31 December 2023. During the last 3 years, it has risen by +$45.06 million (+53.40%). SYRE annual operating expenses is now at all-time high.SYRE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$55.39 M
+$11.24 M+25.47%
30 September 2024
Summary:
Spyre Therapeutics quarterly total operating expenses is currently $55.39 million, with the most recent change of +$11.24 million (+25.47%) on 30 September 2024. Over the past year, it has increased by +$22.15 million (+66.62%). SYRE quarterly operating expenses is now at all-time high.SYRE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.6% | +66.6% |
| 3 y3 years | +53.4% | +130.0% |
| 5 y5 years | +61.1% | +152.8% |
SYRE Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +53.4% | at high | +192.6% |
| 5 y | 5 years | at high | +61.1% | at high | +205.6% |
| alltime | all time | at high | +1353.8% | at high | +6363.5% |
Spyre Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $55.39 M(+25.5%) |
| June 2024 | - | $44.15 M(-7.6%) |
| Mar 2024 | - | $47.77 M(+0.0%) |
| Dec 2023 | $129.45 M(+48.6%) | $47.75 M(+43.6%) |
| Sept 2023 | - | $33.24 M(+12.9%) |
| June 2023 | - | $29.45 M(+55.0%) |
| Mar 2023 | - | $19.00 M(-1.7%) |
| Dec 2022 | $87.11 M(+3.2%) | - |
| Dec 2022 | - | $19.33 M(+2.1%) |
| Sept 2022 | - | $18.93 M(-17.9%) |
| June 2022 | - | $23.05 M(-10.7%) |
| Mar 2022 | - | $25.80 M(+7.1%) |
| Dec 2021 | $84.39 M(+3.6%) | $24.09 M(+11.0%) |
| Sept 2021 | - | $21.69 M(+6.3%) |
| June 2021 | - | $20.40 M(+12.0%) |
| Mar 2021 | - | $18.21 M(-20.1%) |
| Dec 2020 | $81.48 M(+1.4%) | $22.78 M(+25.7%) |
| Sept 2020 | - | $18.12 M(-15.9%) |
| June 2020 | - | $21.56 M(+13.3%) |
| Mar 2020 | - | $19.02 M(-13.2%) |
| Dec 2019 | $80.33 M | $21.91 M(-1.1%) |
| Sept 2019 | - | $22.15 M(+18.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $18.62 M(+5.5%) |
| Mar 2019 | - | $17.66 M(+15.4%) |
| Dec 2018 | $49.35 M(+50.1%) | $15.30 M(+25.0%) |
| Sept 2018 | - | $12.24 M(+1.6%) |
| June 2018 | - | $12.05 M(+23.5%) |
| Mar 2018 | - | $9.76 M(+20.3%) |
| Dec 2017 | $32.88 M(+23.9%) | $8.11 M(-12.4%) |
| Sept 2017 | - | $9.26 M(+12.9%) |
| June 2017 | - | $8.20 M(+12.1%) |
| Mar 2017 | - | $7.31 M(+7.7%) |
| Dec 2016 | $26.53 M(+52.5%) | $6.79 M(-8.9%) |
| Sept 2016 | - | $7.45 M(+8.5%) |
| June 2016 | - | $6.87 M(+26.6%) |
| Mar 2016 | - | $5.43 M(-2.8%) |
| Dec 2015 | $17.40 M(+95.4%) | $5.58 M(+24.3%) |
| Sept 2015 | - | $4.49 M(-7.6%) |
| June 2015 | - | $4.86 M(+96.8%) |
| Mar 2015 | - | $2.47 M(-22.4%) |
| Dec 2014 | $8.90 M | $3.18 M(+1.3%) |
| Sept 2014 | - | $3.14 M(+81.9%) |
| June 2014 | - | $1.73 M(+101.4%) |
| Mar 2014 | - | $857.00 K |
FAQ
- What is Spyre Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Spyre Therapeutics?
- What is Spyre Therapeutics annual operating expenses year-on-year change?
- What is Spyre Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly operating expenses year-on-year change?
What is Spyre Therapeutics annual total operating expenses?
The current annual operating expenses of SYRE is $129.45 M
What is the all time high annual operating expenses for Spyre Therapeutics?
Spyre Therapeutics all-time high annual total operating expenses is $129.45 M
What is Spyre Therapeutics annual operating expenses year-on-year change?
Over the past year, SYRE annual total operating expenses has changed by +$42.34 M (+48.61%)
What is Spyre Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of SYRE is $55.39 M
What is the all time high quarterly operating expenses for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly total operating expenses is $55.39 M
What is Spyre Therapeutics quarterly operating expenses year-on-year change?
Over the past year, SYRE quarterly total operating expenses has changed by +$22.15 M (+66.62%)